Cas:119673-49-3 1-(2-chlorophenyl)-2,5-dimethylpyrrole-3-carbaldehyde manufacturer & supplier

Chemical Name:1-(2-chlorophenyl)-2,5-dimethylpyrrole-3-carbaldehyde

CAS.NO:119673-49-3

Synonyms:N-(o-chlorophenyl)-2,5-dimethylpyrrole-3-carbaldehyde;1H-Pyrrole-3-carboxaldehyde,1-(2-chlorophenyl)-2,5-dimethyl;1-(2-chlorophenyl)-2,5-dimethyl-1H-pyrrole-3-carbaldehyde;N-(2-chlorophenyl)-2,5-dimethylpyrrole-3-carbaldehyde

Molecular Formula:C₁₃H₁₂ClNO

Molecular Weight:233.69300

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:374.2ºC at 760mmHg

Density:1.16g/cm3

Index of Refraction:1.576

PSA:22.00000

Exact Mass:233.06100

LogP:3.56000

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like N-(o-chlorophenyl)-2,5-dimethylpyrrole-3-carbaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-(2-chlorophenyl)-2,5-dimethylpyrrole-3-carbaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(2-chlorophenyl)-2,5-dimethyl-1H-pyrrole-3-carbaldehyde Use and application,1H-Pyrrole-3-carboxaldehyde,1-(2-chlorophenyl)-2,5-dimethyl technical grade,usp/ep/jp grade.

Related News: However, the study did not produce any significant benefits when it came to thinking, reasoning and memory tests performed across the entire patient group — possibly because there were too few people with clinically diagnosed Alzheimer’s participating in the trial. 1-(2-chlorophenyl)-2,5-dimethylpyrrole-3-carbaldehyde manufacturer Biogen has said that some 1.5 million Americans with early-stage Alzheimer’s will be eligible for the drug, priced at an average of $56,000 per year, with the federal Medicare insurance program for seniors likely on the hook for most of the cost. 1-(2-chlorophenyl)-2,5-dimethylpyrrole-3-carbaldehyde supplier Biogen has said that some 1.5 million Americans with early-stage Alzheimer’s will be eligible for the drug, priced at an average of $56,000 per year, with the federal Medicare insurance program for seniors likely on the hook for most of the cost. 1-(2-chlorophenyl)-2,5-dimethylpyrrole-3-carbaldehyde vendor This also includes its anti-tau pipeline, with the FDA’s approval having “implications for AD programmes targeting Tau,” according to Jefferies. 1-(2-chlorophenyl)-2,5-dimethylpyrrole-3-carbaldehyde factory This also includes its anti-tau pipeline, with the FDA’s approval having “implications for AD programmes targeting Tau,” according to Jefferies.